1. Home
  2. LMRI vs BIOA Comparison

LMRI vs BIOA Comparison

Compare LMRI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LMRI

Lumexa Imaging Holdings Inc. Common Stock

N/A

Current Price

$7.41

Market Cap

753.7M

Sector

Health Care

ML Signal

N/A

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$16.11

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMRI
BIOA
Founded
2018
2015
Country
United States
United States
Employees
N/A
62
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
753.7M
681.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LMRI
BIOA
Price
$7.41
$16.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$20.75
$51.50
AVG Volume (30 Days)
946.9K
354.1K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.35
$720.93
Revenue Next Year
$5.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.45
$3.79
52 Week High
$19.45
$24.00

Technical Indicators

Market Signals
Indicator
LMRI
BIOA
Relative Strength Index (RSI) 33.62 42.51
Support Level $7.23 $15.74
Resistance Level $10.53 $19.01
Average True Range (ATR) 0.81 1.31
MACD -0.27 -0.16
Stochastic Oscillator 18.82 30.46

Price Performance

Historical Comparison
LMRI
BIOA

About LMRI Lumexa Imaging Holdings Inc. Common Stock

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: